Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v4-EN
Language English English
Date Updated 2025-01-09 2024-11-19
Drug Identification Number 02519305 02519305
Brand name ACETAMINOPHEN INJECTION ACETAMINOPHEN INJECTION
Common or Proper name Acetaminophen Injection 1000 mg / 100 mL (10 mg/mL) Acetaminophen Injection 1000 mg / 100 mL (10 mg/mL)
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients ACETAMINOPHEN ACETAMINOPHEN
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes CJPE8822– 40 bags/case CJPE8822– 40 bags/case
ATC code N02BE N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-11-11 2024-11-11
Actual start date 2024-11-11 2024-11-11
Estimated end date 2025-01-08 2024-12-06
Actual end date 2025-01-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage is due to increase in market demand in the Canadian market. Shortage is due to increase in market demand in the Canadian market.
Health Canada comments